VANGUARD GROUP INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$879,949
-60.1%
56,881
-59.4%
0.00%
Q2 2023$2,203,092
-7.9%
140,235
-3.4%
0.00%
Q1 2023$2,392,715
-23.8%
145,189
-27.9%
0.00%
Q4 2022$3,141,980
-5.6%
201,409
-21.5%
0.00%
Q3 2022$3,327,000
-70.1%
256,504
-67.7%
0.00%
Q2 2022$11,138,000
-44.5%
793,277
-43.4%
0.00%
Q1 2022$20,070,000
-15.2%
1,401,552
-19.3%
0.00%
-100.0%
Q4 2021$23,674,000
-27.5%
1,736,931
-12.9%
0.00%0.0%
Q3 2021$32,655,000
-22.3%
1,993,608
-20.1%
0.00%0.0%
Q2 2021$42,010,000
-12.7%
2,496,142
-5.3%
0.00%0.0%
Q1 2021$48,117,000
-12.6%
2,635,127
-12.9%
0.00%
-50.0%
Q4 2020$55,051,000
-12.6%
3,024,768
-14.4%
0.00%0.0%
Q3 2020$63,004,000
-22.6%
3,531,592
-22.2%
0.00%
-33.3%
Q2 2020$81,368,000
-5.6%
4,538,071
-20.1%
0.00%
-25.0%
Q1 2020$86,180,000
-26.9%
5,677,186
-5.0%
0.00%0.0%
Q4 2019$117,930,000
+11.4%
5,977,204
-2.9%
0.00%0.0%
Q3 2019$105,846,000
-10.7%
6,153,843
-8.1%
0.00%0.0%
Q2 2019$118,521,000
-13.1%
6,696,1050.0%0.00%
-20.0%
Q1 2019$136,400,0006,696,1050.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders